Product
L-AmB
2 clinical trials
4 indications
Indication
HistoplasmosisIndication
HIV/AIDSIndication
Immune suppressionIndication
Fungal InfectionClinical trial
Efficacy and Safety of High-dose Liposomal Amphotericin B (10 mg/kg) for Disseminated Histoplasmosis in AIDS: a Randomized Phase III Trial (INDUCTION Trial)Status: Not yet recruiting, Estimated PCD: 2025-05-28
Clinical trial
Open Label Phase-II Randomized Trial of Three Liposomal Amphotericin B Regimens as Induction Therapy for Disseminated Histoplasmosis in AIDS PatientsStatus: Completed, Estimated PCD: 2021-12-31